Trial Details

Not Recruiting
Basic Information
Clinical ID c3277
Identifier JPRN-UMIN000002604
Trial Title Combined therapy of infliximab with surgery in maintenance of remission in Crohn's disease - Combined therapy of infliximab with surgery in Crohn's disease
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Crohn's disease
Interventions Patients are randomly divided into two groups, groups treated with or without infliximab by staffs of Keio Clinical Research Center at 2 to 4 weeks after surgery. Patients receive infliximab 5 mg/kg at 0, 2, 6 weeks, followed by every 8 weeks for 2 years. Alternatively, patients continue to receive infliximab with intervals of 8 weeks if they received infliximab within 8 weeks from the time point 0. Patients without infliximab receive maintenance therapy without immunomodulators.
Participant Information
Sponsor Clinical Research Group of inflammatory bowel disease in Japan
City -
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2014-03-01